The Danish biotechnology cluster is a major world player, especially in areas such as enzymes, CNS research, diabetes care and cancer research. A long-standing agricultural tradition created a research industry in Denmark more than 150 years ago and since then, research methods have continuously developed in Denmark.
Looking to locate in one of Europe’s strongest biotech clusters?
Denmark is the European leader in drug development and has the third largest commercial drug development pipeline in Europe in absolute numbers. Medicon Valley, one of Europe’s top three sites for biotech innovation alongside Cambridge in the United Kingdom and Basel in Switzerland, spearheads the Danish biotech cluster with a strong presence and close collaboration between universities, hospitals and companies.
Top 3 reasons for placing biotech business activities in Denmark
• Denmark is home to the 3rd largest commercial drug development pipeline in Europe – in actual numbers - giving access to innovative R&D skills in Denmark (Ernst and Young, Beyond borders 2012)
• Denmark has the 3rd largest market capitalization of biotech companies in Europe (Ernst and Young, Biotech in Denmark 2011)
• Denmark is ranked second in biotechnology innovation with the top score on intensity of biotechnology innovation (Scientific American Worldview Scorecard)
Danish biotech areas of business excellence